W. R. Frontera and J. Ochala, Skeletal muscle: a brief review of structure and function, Calcif Tissue Int, vol.96, pp.183-95, 2015.

J. C. Carter, D. W. Sheehan, A. Prochoroff, and D. J. Birnkrant, Muscular dystrophies, Clin Chest Med, vol.39, pp.377-89, 2018.

S. Al-zaidy, L. Rodino-klapac, and J. R. Mendell, Gene therapy for muscular dystrophy: moving the field forward, Pediatr Neurol, vol.51, pp.607-625, 2014.

T. Gaj, C. A. Gersbach, C. F. Barbas, T. Zfn, and C. , Cas-based methods for genome engineering, Trends Biotechnol, vol.31, pp.397-405, 2013.

H. Nishimasu, F. A. Ran, and P. D. Hsu, Crystal structure of Cas9 in complex with guide RNA and target DNA, Cell, vol.156, pp.935-984, 2014.

F. Jiang and J. A. Doudna, CRISPR-Cas9 Structures and Mechanisms, Annu Rev Biophys, vol.46, pp.505-534, 2017.

X. H. Zhang, L. Y. Tee, and X. G. Wang, Off-target effects in CRISPR/Cas9-mediated genome engineering, Mol Ther Nucleic Acids, vol.4, p.264, 2015.

N. K. Aryal, A. R. Wasylishen, and G. Lozano, CRISPR/Cas9 can mediate highefficiency off-target mutations in mice in vivo, Cell Death Dis, vol.9, p.1099, 2018.

S. Neldeborg, L. Lin, M. Stougaard, and Y. Luo, Rapid and efficient gene deletion by CRISPR/Cas9, Methods Mol Biol, pp.233-280, 1961.

Y. L. Min, R. Bassel-duby, and E. N. Olson, CRISPR correction of Duchenne muscular dystrophy, Annu Rev Med, vol.70, pp.239-55, 2019.

Y. Wang, L. Hao, and H. Wang, Therapeutic genome editing for myotonic dystrophy type 1 using CRISPR/Cas9, Mol Ther, vol.26, pp.2617-2647, 2018.

C. Long, J. R. Mcanally, and J. M. Shelton, Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA, Science, vol.345, pp.1184-1192, 2014.

N. E. Bengtsson, J. K. Hall, and G. L. Odom, Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy, Nat Commun, vol.8, p.14454, 2017.

P. R. Matre, X. Mu, and J. Wu, CRISPR/Cas9-based dystrophin restoration reveals a novel role for dystrophin in bioenergetics and stress resistance of muscle Pprogenitors, Stem Cells, vol.37, pp.1615-1643, 2019.

J. Hwang and T. Yokota, Recent advancements in exon-skipping therapies using antisense oligonucleotides and genome editing for the treatment of various muscular dystrophies, Expert Rev Mol Med, vol.21, p.5, 2019.

S. M. Ryu, T. Koo, and K. Kim, Adenine base editing in mouse embryos and an adult mouse model of Duchenne muscular dystrophy, Nat Biotechnol, vol.36, pp.536-545, 2018.

V. Ricotti, S. Spinty, and H. Roper, Safety, tolerability, and pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole utrophin modulator, following singleand multiple-dose administration to pediatric patients with Duchenne muscular dystrophy, PLoS One, vol.11, p.152840, 2016.

K. S. Hanlon, B. P. Kleinstiver, and S. P. Garcia, High levels of AAV vector integration into CRISPR-induced DNA breaks, Nat Commun, vol.10, p.4439, 2019.

J. Lee, H. Mou, and R. Ibraheim, Tissue-restricted genome editing in vivo specified by microRNA-repressible anti-CRISPR proteins, RNA, vol.25, pp.1421-1452, 2019.

Y. L. Min, R. Bassel-duby, and E. N. Olson, CRISPR correction of Duchenne muscular dystrophy, Annu Rev Med, vol.70, pp.239-55, 2019.

J. Cohen, In dogs, CRISPR fixes a muscular dystrophy, Science, vol.361, p.835, 2018.

F. J. Attenello, Immunity to CRISPR-Cas9, Sci Transl Med, vol.1, p.5328, 2019.

J. M. Crudele and J. S. Chamberlain, Cas9 immunity creates challenges for CRISPR gene editing therapies, Nat Commun, vol.9, p.3497, 2018.

C. T. Charlesworth, P. S. Deshpande, and D. P. Dever, Identification of preexisting adaptative immunity to Cas9 proteins in humans, Nat Med, vol.25, pp.249-54, 2019.

E. Neuberger and P. Simon, Gene and cell doping: the new frontier. Beyond myth or reality, Med Sport Sci, vol.62, pp.91-106, 2017.

M. Schuelke, K. R. Wagner, and L. E. Stolz, Myostatin mutation associated with gross muscle hypertrophy in a child, N Engl J Med, vol.350, pp.2682-2690, 2004.

A. Rossi and A. Salvetti, Intégration des vecteurs AAV et mutagenèse insertionnelle, Med Sci (Paris), vol.32, pp.167-74, 2016.

M. Meyer, Biologie et médecine « do-it-yourself ». Histoire, pratiques, enjeux, Med Sci, vol.34, pp.473-482, 2018.

P. Gee, H. Xu, and A. Hotta, Cellular reprogramming, genome editing, and alternative CRISPR Cas9 technologies for precise gene therapy of Duchenne muscular dystrophy, Stem Cells Int, vol.8765154, 2017.

G. Chen, A. A. Abdeen, and Y. Wang, A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing, Nat Nanotechnol, vol.14, pp.974-80, 2019.

K. Lee, M. Conboy, and H. M. Park, Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair, Nat Biomed Eng, vol.1, pp.889-901, 2017.

C. H. Lau and Y. Suh, In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease, F1000Res, vol.6, p.2153, 2017.

K. Nakamura, W. Fujii, and M. Tsuboi, Generation of muscular dystrophy model rats with a CRISPR/ Cas system, Sci Rep, vol.4, p.5635, 2014.

L. Amoasii, C. Long, and H. Li, Single-cut genome editing restores dystrophin expression in a new mouse model of muscular dystrophy, Sci Transl Med, vol.9, 2017.

T. Sui, Y. S. Lau, and D. Liu, A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9, Dis Model Mech, vol.11, 2018.

Y. Chen, Y. Zheng, and Y. Kang, Functional disruption of the dystrophin gene in rhesus monkey using CRISPR/Cas9, Hum Mol Genet, vol.24, pp.3764-74, 2015.

A. R. Demonbreun, E. J. Wyatt, and K. S. Fallon, A gene-edited mouse model of Limb-Girdle muscular dystrophy 2C for testing exon skipping, Dis Model Mech, vol.13, p.40832, 2019.

S. Brennan, M. Garcia-castaneda, and A. Michelucci, Mouse model of severe recessive RYR1-related myopathy, Hum Mol Genet, vol.28, pp.3024-3060, 2019.

L. Amoasii, H. Li, and Y. Zhang, In vivo non-invasive monitoring of dystrophin correction in a new Duchenne muscular dystrophy reporter mouse, Nat Commun, vol.10, p.4537, 2019.

L. Amoasii, J. Hildyard, and H. Li, Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy, Science, vol.362, pp.86-91, 2018.

C. Long, L. Amoasii, and A. A. Mireault, Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy, Science, vol.351, pp.400-403, 2016.

M. Ifuku, K. A. Iwabuchi, and M. Tanaka, Restoration of dystrophin protein expression by exon skipping utilizing CRISPR-Cas9 in myoblasts derived from DMD patient iPS cells, Methods Mol Biol, vol.1828, pp.191-217, 2018.

C. Long, H. Li, and M. Tiburcy, Correction of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing, Sci Adv, vol.4, p.9004, 2018.

B. L. Duchêne, K. Cherif, and J. P. Iyombe-engembe, CRISPR-induced deletion with SaCas9 restores dystrophin expression in dystrophic models in vitro and in vivo, Mol Ther, vol.26, pp.2604-2620, 2018.

M. E. Nance, R. Shi, and C. H. Hakim, AAV9 edits muscle stem cells in normal and dystrophic adult mice, Mol Ther, vol.27, pp.1568-85, 2019.

M. Tabebordbar, K. Zhu, and J. Cheng, In vivo gene editing in dystrophic mouse muscle and muscle stem cells, Science, vol.351, pp.407-418, 2016.

C. E. Nelson, C. H. Hakim, and D. G. Ousterout, In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy, Science, vol.351, pp.403-410, 2016.

S. Dastidar, S. Ardui, K. Singh, and L. Et, Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells, Nucleic Acids Res, vol.46, pp.8275-98, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02357315

M. Lo-scrudato, K. Poulard, and C. Sourd, Genome editing of expanded CTG repeats within the human DMPK gene reduces nuclear RNA foci in muscle of DM1 mice, Mol Ther, vol.27, pp.1372-88, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02177548

S. Selvaraj, N. R. Dhoke, and J. Kiley, Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy, Mol Ther, vol.27, pp.2147-57, 2019.